Compare Amphastar Pharmaceuticals Inc (AMPH) vs State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF (SJNK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF — how do they compare? Amphastar Pharmaceuticals Inc trades at $19.75 (market cap $868.62M), while State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF trades at $24.87. Which is the better fit depends on your goals.
| AMPH | SJNK | |
|---|---|---|
Market Cap | $868.62M | — |
Sector | Health | Sector/Thematic |
52-Week High | $30.81 | $25.63 |
52-Week Low | $16.87 | $24.75 |
Enterprise Value | $1.27B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF
SJNK invests in U.S. dollar-denominated high-yield corporate bonds with short-term maturities (under five years). It offers higher yields than investment-grade funds but with less interest rate sensitivity than longer-term junk bond ETFs.
Read more on SJNK →
